/Baxter%20International%20Inc_%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
Valued at a market cap of $18.7 billion, Baxter International Inc. (BAX) is a leading global medical technology company. Based in Deerfield, Illinois, it specializes in diverse healthcare products, focusing on renal care, hospital solutions, and pharmaceuticals to improve patient outcomes worldwide. The company is expected to unveil its fiscal Q3 earnings results before the market opens on Friday, Nov. 8.
Ahead of the event, analysts forecast the drug and medical device maker to post a profit of $0.78 per share, reflecting a growth of 14.7% from $0.68 per share in the same quarter last year. The company has consistently surpassed Wall Street's bottom-line projections in the past four quarters. BAX surpassed the consensus EPS estimate by a margin of 3% in the last reported quarter.
